Actively Recruiting
Global Overweight and oBesE (GLOBE) Patient Registry, Development and Implementation of Disease-specific: Severity, Quality of Life and Cost Instruments.
Led by Medialis Ltd. · Updated on 2025-11-14
500
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting this observational study to create specialized tools that measure the severity, quality of life, and costs related to overweight and obesity for individuals with a body mass index (BMI) over 25. The study highlights the lack of comprehensive instruments for people who are overweight or extremely obese, especially those not receiving certain treatments like GLP-1 therapy. It aims to combine patient and clinician perspectives to improve severity measures and support early intervention strategies. The study involves systematically assessing symptoms, comorbidities, health-related quality of life (HRQoL), and economic impacts across a wide range of participants with BMI above 25. It excludes those on GLP-1 therapy. There are no drug or device interventions; instead, participants complete surveys and questionnaires that help develop disease-specific and quality of life instruments over about two months. Participants will be involved in completing surveys and study activities in English, reporting their BMI and health status. The main outcome is the development of a disease-specific questionnaire within two months, along with a quality of life tool. Researchers will collect data on symptoms, costs, and patient experiences to better understand the burden of overweight and obesity. Participation is voluntary, and the study includes adults aged 18 and older.
CONDITIONS
Brief Title
Global Overweight and oBesE (GLOBE) Patient Registry, Development and Implementation of Disease-specific: Severity, Quality of Life and Cost Instruments.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient or healthcare professional aged 18 years or older at the time of survey completion
- Patient has a BMI over 25 (self-reported)
- Participant is willing to participate in all study activities
- Participant can read, write, and converse in English
- Healthcare professional is suitably qualified and involved in managing patients with BMI over 25
You will not qualify if you...
- Lack of cognitive capacity to provide informed consent
- Severe co-morbid conditions that might affect study participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - Up to 2 months
Participants complete surveys and questionnaires to evaluate symptoms, comorbidities, quality of life, and costs related to BMI over 25.
1 to 2 survey sessions
Trial Site Locations
Total: 1 location
1
Online recruitment
Milton Keynes, United Kingdom, MK12 5NW
Actively Recruiting
Research Team
O
Omolade Allen, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here